Reference : Coupling of Liquid Chromatography/Tandem Mass Spectrometry and Liquid Chromatography/...
Scientific journals : Article
Human health sciences : Pharmacy, pharmacology & toxicology
http://hdl.handle.net/2268/28404
Coupling of Liquid Chromatography/Tandem Mass Spectrometry and Liquid Chromatography/Solid-Phase Extraction/NMR Techniques for the Structural Identification of Metabolites following In Vitro Biotransformation of SUR1-Selective ATP-Sensitive Potassium Channel Openers
English
Gillotin, F. [> > > >]
Chiap, Patrice [Centre Hospitalier Universitaire de Liège - CHU > > Pharmacologie clinique >]
Frederich, Michel mailto [Université de Liège - ULg > Département de pharmacie > Pharmacognosie >]
Van Heugen, Jean-Claude mailto [Centre Hospitalier Universitaire de Liège - CHU > > Chimie médicale >]
Francotte, Pierre mailto [Université de Liège - ULg > Département de pharmacie > Chimie pharmaceutique >]
Lebrun, Pierre mailto [Université de Liège - ULg > Département de pharmacie > Chimie analytique >]
Pirotte, Bernard mailto [Université de Liège - ULg > Département de pharmacie > Chimie pharmaceutique >]
De Tullio, Pascal mailto [Université de Liège - ULg > Département de pharmacie > Chimie pharmaceutique >]
2010
Drug Metabolism and Disposition : The Biological Fate of Chemicals
Williams and Wilkins
38
2
232-240
Yes (verified by ORBi)
International
0090-9556
1521-009X
Baltimore
MD
[en] SUR1-selective ATP-sensitive potassium channel openers (PCOs) have been shown to be of clinical value for the treatment of several metabolic disorders, including type I and type II diabetes, obesity and hyperinsulinemia. Taking into account these promising therapeutic benefits, different series of 3-alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides structurally related to diazoxide were developed. In view of the lead optimisation process of the series, knowledge of ADMET parameters, and more particularly the metabolic fate of these compounds, is a fundamental requirement. For such a purpose, two selected promising compounds (BPDZ 73 and BPDZ 157) were incubated in the presence of phenobarbital-induced rat liver microsomes to produce expected mammal in vivo phase I metabolites. The resulting major metabolites were then analysed by both MS and NMR in order to completely elucidate their chemical structures. The two compounds were also further incubated in the presence of non-treated rats and human microsomes in order to compare the metabolic profiles. In the present study, the combined use of an exact mass LC-MS/MS platform and a LC-SPE-NMR system allowed the clarification of some unresolved structural assessments in the accurate chemical structure elucidation process of the selected PCOs drugs. These results greatly help the optimization of the lead compounds.
http://hdl.handle.net/2268/28404
10.1124/dmd.109.028928
http://www.ncbi.nlm.nih.gov/entrez/utils/fref.fcgi?PrId=3051&itool=Abstract-def&uid=19875500&nlmid=9421550&db=pubmed&url=http://dmd.aspetjournals.org/cgi/pmidlookup?view=long&pmid=19875500

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
dmd.109.028928.full.pdfAuthor postprint5.37 MBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.